{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T12:01:30Z","timestamp":1784635290787,"version":"3.55.0"},"reference-count":40,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biology"],"abstract":"<jats:p>Specialized pro-resolving mediators (SPMs) are endogenous lipid mediators that actively orchestrate the resolution of inflammation rather than relying solely on broad suppression of inflammatory signaling. At the ocular surface, lipoxins, resolvins, protectins, maresins, and related pro-resolving mediators regulate epithelial repair, leukocyte responses, angiogenesis, conjunctival goblet-cell secretion, tear-film homeostasis, and corneal nerve regeneration. This review synthesizes evidence for local SPM biosynthesis and receptor signaling in the cornea and conjunctiva, together with tear lipid mediator profiling, with emphasis on anterior-segment and ocular-surface disease models. Particular attention is given to the endogenous lipoxin A4 circuit, resolvin-mediated control of corneal inflammation and viral keratitis, docosanoid regulation of corneal nerve regeneration, SPM modulation of conjunctival goblet-cell mucin secretion, tear lipid mediator signatures, and the translational development of resolvin E1 (RvE1)-based analogs for dry eye disease. Current evidence positions SPMs as mechanistically distinct therapeutic candidates for ocular-surface disease; however, clinical translation will require optimized delivery, biomarker-guided patient selection, and rigorous validation in disease-state cohorts.<\/jats:p>","DOI":"10.3390\/biology15141203","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T10:35:52Z","timestamp":1784630152000},"page":"1203","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Specialized Pro-Resolving Mediators at the Ocular Surface: Biosynthesis, Mechanisms, and Therapeutic Potential"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-4839-5182","authenticated-orcid":false,"given":"Siddharth","family":"Gandhi","sequence":"first","affiliation":[{"name":"Faculty of Medicine, Queen\u2019s University, Kingston, ON K7L 3L4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arveen","family":"Shokravi","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Calgary, Calgary, AB T2N 2T8, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sydney","family":"Buhrow","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University of Western Ontario, London, ON N6A 3K7, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5948-0331","authenticated-orcid":false,"given":"Michael","family":"Balas","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, M5T 3A9 ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jtos.2017.05.003","article-title":"TFOS DEWS II Epidemiology Report","volume":"15","author":"Stapleton","year":"2017","journal-title":"Ocul. Surf."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1001\/archopht.1963.00960050494011","article-title":"Effect of Corticosteroids on Intraocular Pressure and Fluid Dynamics: The Effect of Dexamethasone in the Glaucomatous Eye","volume":"70","author":"Armaly","year":"1963","journal-title":"Arch. Ophthalmol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1476-9255-11-6","article-title":"Anti-Inflammatory Effects of Resolvin-D1 on Human Corneal Epithelial Cells: In Vitro Study","volume":"11","author":"Erdinest","year":"2014","journal-title":"J. Inflamm."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.mam.2017.03.006","article-title":"The Role of Pro-Resolving Lipid Mediators in Ocular Diseases","volume":"58","author":"Wei","year":"2017","journal-title":"Mol. Asp. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1172\/JCI97943","article-title":"Resolvins in Inflammation: Emergence of the pro-Resolving Superfamily of Mediators","volume":"128","author":"Serhan","year":"2018","journal-title":"J. Clin. Investig."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nri2294","article-title":"Resolving Inflammation: Dual Anti-Inflammatory and pro-Resolution Lipid Mediators","volume":"8","author":"Serhan","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"5922","DOI":"10.1021\/cr100396c","article-title":"Resolvins and Protectins in Inflammation Resolution","volume":"111","author":"Serhan","year":"2011","journal-title":"Chem. Rev."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"15267","DOI":"10.1074\/jbc.M410638200","article-title":"A Role for the Mouse 12\/15-Lipoxygenase Pathway in Promoting Epithelial Wound Healing and Host Defense","volume":"280","author":"Gronert","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Deng, B., Wang, C.-W., Arnardottir, H.H., Li, Y., Cheng, C.-Y.C., Dalli, J., and Serhan, C.N. (2014). Maresin Biosynthesis and Identification of Maresin 2, a New Anti-Inflammatory and pro-Resolving Mediator from Human Macrophages. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0102362"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1096\/fj.13-227728","article-title":"The Novel 13S,14S-Epoxy-Maresin Is Converted by Human Macrophages to Maresin 1 (MaR1), Inhibits Leukotriene A4 Hydrolase (LTA4H), and Shifts Macrophage Phenotype","volume":"27","author":"Dalli","year":"2013","journal-title":"FASEB J."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1038\/mi.2013.7","article-title":"Resolvin D1 and Aspirin-Triggered Resolvin D1 Regulate Histamine-Stimulated Conjunctival Goblet Cell Secretion","volume":"6","author":"Li","year":"2013","journal-title":"Mucosal Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Lyngstadaas, A.V., Olsen, M.V., Bair, J.A., Hodges, R.R., Utheim, T.P., Serhan, C.N., and Dartt, D.A. (2021). Pro-Resolving Mediator Annexin A1 Regulates Intracellular Ca2+ and Mucin Secretion in Cultured Goblet Cells Suggesting a New Use in Inflammatory Conjunctival Diseases. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.618653"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"36124","DOI":"10.1038\/srep36124","article-title":"Lipoxin A4 Counter-Regulates Histamine-Stimulated Glycoconjugate Secretion in Conjunctival Goblet Cells","volume":"6","author":"Hodges","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"12298","DOI":"10.1111\/jcmm.15633","article-title":"Resolvin D1 Attenuates the Inflammatory Process in Mouse Model of LPS-Induced Keratitis","volume":"24","author":"Petrillo","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.exer.2018.11.018","article-title":"Resolvin D1, but Not Resolvin E1, Transactivates the Epidermal Growth Factor Receptor to Increase Intracellular Calcium and Glycoconjugate Secretion in Rat and Human Conjunctival Goblet Cells","volume":"180","author":"Kaye","year":"2019","journal-title":"Exp. Eye Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/j.ajpath.2020.06.001","article-title":"Resolvin E1 Reduces Leukotriene B4-Induced Intracellular Calcium Increase and Mucin Secretion in Rat Conjunctival Goblet Cells","volume":"190","author":"Yang","year":"2020","journal-title":"Am. J. Pathol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/jcp.29846","article-title":"Maresin 1, a Specialized Proresolving Mediator, Stimulates Intracellular [Ca2+] and Secretion in Conjunctival Goblet Cells","volume":"236","author":"Olsen","year":"2021","journal-title":"J. Cell. Physiol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Olsen, M.V., Lyngstadaas, A.V., Bair, J.A., Hodges, R.R., Utheim, T.P., Serhan, C.N., and Dartt, D.A. (2022). Signaling Pathways Used by the Specialized Pro-Resolving Mediator Maresin 2 Regulate Goblet Cell Function: Comparison with Maresin 1. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23116233"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.exer.2018.04.015","article-title":"Signaling Pathways Activated by Resolvin E1 to Stimulate Mucin Secretion and Increase Intracellular Ca2+ in Cultured Rat Conjunctival Goblet Cells","volume":"173","author":"Lippestad","year":"2018","journal-title":"Exp. Eye Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1097\/ICO.0b013e31823f789e","article-title":"Resolvin E1 (RX-10001) Reduces Corneal Epithelial Barrier Disruption and Protects Against Goblet Cell Loss in a Murine Model of Dry Eye","volume":"31","author":"Schwartz","year":"2012","journal-title":"Cornea"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1089\/jop.2010.0019","article-title":"Resolvin E1 Improves Tear Production and Decreases Inflammation in a Dry Eye Mouse Model","volume":"26","author":"Li","year":"2010","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"ref_22","first-page":"274","article-title":"Resolvin D1 Promotes Corneal Epithelial Wound Healing and Restoration of Mechanical Sensation in Diabetic Mice","volume":"24","author":"Zhang","year":"2018","journal-title":"Mol. Vis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"4582","DOI":"10.1038\/s41598-020-61390-8","article-title":"Novel RvD6 Stereoisomer Induces Corneal Nerve Regeneration and Wound Healing Post-Injury by Modulating Trigeminal Transcriptomic Signature","volume":"10","author":"Pham","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1167\/iovs.09-3641","article-title":"Neuroprotectin D1 Synthesis and Corneal Nerve Regeneration after Experimental Surgery and Treatment with PEDF plus DHA","volume":"51","author":"Cortina","year":"2010","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"100033","DOI":"10.1194\/jlr.TR120000954","article-title":"Docosanoid Signaling Modulates Corneal Nerve Regeneration: Effect on Tear Secretion, Wound Healing, and Neuropathic Pain","volume":"62","author":"Pham","year":"2021","journal-title":"J. Lipid Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1096\/fj.06-7918com","article-title":"Interdependence of Lipoxin A4 and Heme-oxygenase in Counter-regulating Inflammation during Corneal Wound Healing","volume":"21","author":"Biteman","year":"2007","journal-title":"FASEB J."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1167\/iovs.10-6199","article-title":"EGF Stimulates Lipoxin A4 Synthesis and Modulates Repair in Corneal Epithelial Cells through ERK and P38 Activation","volume":"52","author":"Kenchegowda","year":"2011","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"74","DOI":"10.2353\/ajpath.2010.090678","article-title":"Endogenous LXA4 Circuits Are Determinants of Pathological Angiogenesis in Response to Chronic Injury","volume":"176","author":"Leedom","year":"2010","journal-title":"Am. J. Pathol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"He, J., Pham, T.L., Kakazu, A.H., Ponnath, A., Do, K.V., and Bazan, H.E.P. (2023). Lipoxin A4 (LXA4) Reduces Alkali-Induced Corneal Inflammation and Neovascularization and Upregulates a Repair Transcriptome. Biomolecules, 13.","DOI":"10.3390\/biom13050831"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.4049\/jimmunol.1003456","article-title":"Controlling Herpes Simplex Virus-Induced Ocular Inflammatory Lesions with the Lipid-Derived Mediator Resolvin E1","volume":"186","author":"Rajasagi","year":"2011","journal-title":"J. Immunol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1189\/jlb.3HI1216-511RR","article-title":"Frontline Science: Aspirin-Triggered Resolvin D1 Controls Herpes Simplex Virus-Induced Corneal Immunopathology","volume":"102","author":"Rajasagi","year":"2017","journal-title":"J. Leukoc. Biol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.plefa.2017.01.004","article-title":"Identification and Profiling of Specialized Pro-Resolving Mediators in Human Tears by Lipid Mediator Metabolomics","volume":"117","author":"English","year":"2017","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.exer.2014.09.012","article-title":"The Corneal Fibrosis Response to Epithelial-Stromal Injury","volume":"142","author":"Torricelli","year":"2016","journal-title":"Exp. Eye Res."},{"key":"ref_34","first-page":"1710","article-title":"Resolvin E1 Analog RX-10045 0.1% Reduces Corneal Stromal Haze in Rabbits When Applied Topically after PRK","volume":"20","author":"Torricelli","year":"2014","journal-title":"Mol. Vis."},{"key":"ref_35","unstructured":"Resolvyx Pharmaceuticals, Inc. (2026, June 06). A Phase II, Multi-Center, Double-Masked, Randomized, Placebo Controlled, Study on the Safety and Efficacy of RX-10045 on the Signs and Symptoms of Dry Eye in Every Day Environmental Conditions and During Provocation Using the Controlled Adverse Environment (CAE) Model, Available online: https:\/\/clinicaltrials.gov\/study\/NCT01675570."},{"key":"ref_36","unstructured":"C.T. Development America, Inc. (2026, June 06). A Phase II, Multi-Center, Randomized, Placebo-Controlled, Double-Masked Study of RX-10045 (0.09%) in the Treatment of Dry Eye Disease, Available online: https:\/\/clinicaltrials.gov\/study\/NCT00799552."},{"key":"ref_37","unstructured":"(2026, June 27). Resolvyx Announces Positive Data from Phase 2 Clinical Trial of the Resolvin RX-10045 in Patients with Dry Eye Syndrome. Available online: https:\/\/www.flagshippioneering.com\/news\/press-release\/resolvyx-announces-positive-data-phase-2-clinical-trial-resolvin-rx-10045-patients-dry-ey."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.2147\/DDDT.S112389","article-title":"Resolvins and Aliamides: Lipid Autacoids in Ophthalmology\u2014What Promise Do They Hold?","volume":"10","author":"Hesselink","year":"2016","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1089\/jop.2014.0144","article-title":"Interaction Studies of Resolvin E1 Analog (RX-10045) with Efflux Transporters","volume":"31","author":"Cholkar","year":"2015","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ijpharm.2015.12.037","article-title":"Topical Delivery of Aqueous Micellar Resolvin E1 Analog (RX-10045)","volume":"498","author":"Cholkar","year":"2016","journal-title":"Int. J. Pharm."}],"container-title":["Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-7737\/15\/14\/1203\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T11:08:01Z","timestamp":1784632081000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-7737\/15\/14\/1203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":40,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["biology15141203"],"URL":"https:\/\/doi.org\/10.3390\/biology15141203","relation":{},"ISSN":["2079-7737"],"issn-type":[{"value":"2079-7737","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,21]]}}}